Download Sample
Add to CartGlobal Virus Filtration Market Growth, Share, Size, Trends and Forecast (2025 - 2031)
By Technology;
Filtration and ChromatographyBy Product;
Consumables, Instruments, and ServicesBy Application;
Biologicals, Medical Devices, and Water PurificationBy End-User;
Hospitals & Clinics, Pharmaceutical Companies, Medical Device Companies, Contract Testing Organizations, and OthersBy Geography;
North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)Virus Filtration Market Overview
Virus Filtration Market (USD Million)
Virus Filtration Market was valued at USD 5,196.15 million in the year 2024. The size of this market is expected to increase to USD 11,415.43 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 11.9%.
Global Virus Filtration Market Growth, Share, Size, Trends and Forecast
*Market size in USD million
CAGR 11.9 %
| Study Period | 2025 - 2031 |
|---|---|
| Base Year | 2024 |
| CAGR (%) | 11.9 % |
| Market Size (2024) | USD 5,196.15 Million |
| Market Size (2031) | USD 11,415.43 Million |
| Market Concentration | Low |
| Report Pages | 375 |
Major Players
- Merck KGaA
- Danaher
- Sartorius AG
- Thermo Fisher Scientific Inc
- GE Healthcare
- Charles River Laboratories
- Asahi Kasei Medical Co Ltd
- WuXi AppTec
- Lonza
- Clean Biologics
Market Concentration
Consolidated - Market dominated by 1 - 5 major players
Global Virus Filtration Market
Fragmented - Highly competitive market without dominant players
The virus filtration market is experiencing steady expansion, driven by the critical need to ensure biopharmaceutical purity and safety. As the production of vaccines and therapeutic proteins increases, filtration solutions are becoming essential to eliminate viral contaminants. Currently, more than 55% of biologics manufacturers employ virus filtration techniques during downstream processing to uphold quality standards.
Surge in Biologic-Based Treatments Boosting Demand
With biologic drugs accounting for over 60% of newly approved therapies, the necessity for effective virus removal is intensifying. These treatments, including monoclonal antibodies and recombinant proteins, require virus filtration as a safeguard step. The growing preference for biologic-based healthcare solutions has made virus filtration indispensable to modern pharmaceutical manufacturing.
Advances in Filtration Technology Supporting Efficiency
Innovations in filter design and membrane materials are driving improvements in virus retention capabilities. Around 40% of filtration systems now utilize advanced nanofiber materials, offering higher precision and throughput. These technological upgrades are not only reducing downtime but also helping manufacturers meet increasing production demands while maintaining product integrity.
Sustained Market Momentum Fueled by Biosafety Priorities
Virus filtration continues to gain momentum as biosafety becomes a core priority in biomanufacturing. Approximately 65% of contract manufacturing service providers now integrate virus filtration as part of their routine offerings. The market is poised for further growth, driven by ongoing research, evolving therapeutic approaches, and heightened safety requirements.
Virus Filtration Market Recent Developments
-
In February 2025, Thermo Fisher Scientific agreed to acquire Solventum’s purification & filtration unit for approximately 4.1 billion, aiming to boost its virus filtration capabilities and strengthen its bioprocessing portfolio.
-
In October 2024, Asahi Kasei Medical launched the Planova FG1 virus removal filter, offering seven‑fold increased flux to enhance efficiency in biopharmaceutical manufacturing.
Virus Filtration Market Segment Analysis
In this report, the Virus Filtration Market has been segmented by Technology, Product, Application, Product, End-User and Geography.
Virus Filtration Market, Segmentation by Technology
The Virus Filtration Market has been segmented by Technology into Filtration and Chromatography.
Filtration
Filtration dominates the virus filtration market, contributing approximately 74% of global revenue in 2022. This technology is widely used in biopharmaceutical manufacturing for its ability to effectively remove viral contaminants while maintaining product quality. The increasing adoption of single-use technologies and membrane filtration systems drives growth in this segment.
Chromatography
Chromatography holds an estimated 26% share of the virus filtration market. This technology is used for both viral removal and viral clearance validation in bioprocessing. Its application in plasma fractionation and monoclonal antibody production supports market expansion. Advancements in chromatographic techniques continue to enhance process efficiency and selectivity.
Virus Filtration Market, Segmentation by Product
The Virus Filtration Market has been segmented by Product into Consumables, Instruments and Services.
Consumables
Consumables dominate the virus filtration market, contributing approximately 59% of global revenue in 2022. This category includes filters, membranes, and cartridges used in biopharmaceutical manufacturing and research applications. The growing demand for single-use systems and high-capacity filtration solutions supports this segment’s growth.
Instruments
Instruments hold an estimated 27% share of the virus filtration market. This segment encompasses filtration systems, chromatography equipment, and automated platforms used to ensure virus removal and process efficiency. Continuous advancements in filtration and chromatography technology fuel demand in this segment.
Services
Services contribute around 14% of the virus filtration market. These include validation, maintenance, and consulting services provided to support bioprocessing operations. Increasing regulatory requirements and the need for process optimization drive demand for specialized virus filtration services.
Virus Filtration Market, Segmentation by Application
The Virus Filtration Market has been segmented by Application into Biologicals, Medical Devices and Water Purification.
Biologicals
Biologicals dominate the virus filtration market, contributing approximately 67% of global revenue in 2022. This segment includes monoclonal antibodies, recombinant proteins, vaccines, and gene therapy products. The rising demand for biopharmaceuticals and the need for stringent viral clearance processes drive strong growth in this segment.
Medical Devices
Medical Devices hold an estimated 21% share of the virus filtration market. These include implantable devices and tubing systems that require viral contamination prevention during manufacturing. Increasing adoption of virus filtration technologies in medical device production enhances safety and compliance.
Water Purification
Water Purification accounts for around 12% of the virus filtration market. Virus filtration is essential for ensuring microbiological safety in pharmaceutical manufacturing and laboratory applications. Growing concerns about waterborne viral contaminants and the need for high-purity water drive this segment’s growth.
Virus Filtration Market, Segmentation by End-User
The Virus Filtration Market has been segmented by End-User into Hospitals and Clinics, Pharmaceutical Companies, Medical Device Companies, Contract Testing Organizations and Others.
Hospitals and Clinics
Hospitals and Clinics contribute approximately 24% of the virus filtration market revenue in 2022. These facilities require virus filtration solutions for applications such as water purification and the preparation of sterile fluids. Increasing focus on infection control and patient safety drives demand in this segment.
Pharmaceutical Companies
Pharmaceutical Companies dominate the virus filtration market, contributing around 46% of global revenue. These organizations use virus filtration technologies to ensure product safety and compliance during biopharmaceutical manufacturing. Growing demand for biologics and gene therapy products supports strong growth in this segment.
Medical Device Companies
Medical Device Companies hold an estimated 14% share of the virus filtration market. These companies use filtration systems to prevent viral contamination during the production of implantable devices and other high-risk components. The focus on quality assurance and regulatory compliance supports demand.
Contract Testing Organizations
Contract Testing Organizations contribute approximately 10% of the virus filtration market revenue. These organizations provide virus clearance testing and validation services for biopharmaceutical companies and medical device manufacturers. The increasing complexity of biologic products and rising outsourcing trends drive growth in this segment.
Others
The "Others" category, including research institutions and academic labs, holds an estimated 6% share of the virus filtration market. These entities use filtration technologies for scientific research and method development, supporting innovations in virus removal strategies and bioprocessing techniques.
Virus Filtration Market, Segmentation by Geography
In this report, the Virus Filtration Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Regions and Countries Analyzed in this Report
Virus Filtration Market Share (%), by Geographical Region
North America
North America leads the virus filtration market, accounting for approximately 42% of global revenue in 2022. This region benefits from advanced biopharmaceutical manufacturing infrastructure, strong regulatory frameworks, and the presence of major market players. The rising demand for biologics and gene therapy products further fuels market growth.
Europe
Europe holds around 28% of the global virus filtration market. Growth in this region is supported by increasing investment in bioprocessing technologies, expanding pharmaceutical manufacturing, and strong emphasis on product safety. Collaboration between industry and regulatory bodies enhances regional growth.
Asia Pacific
Asia Pacific accounts for an estimated 20% share of the virus filtration market. Rapidly improving healthcare infrastructure, rising biopharmaceutical investments, and increasing demand for high-quality biologics drive growth. Countries such as China, India, and Japan are key contributors, fueled by growing clinical research activities and regulatory approvals.
Middle East and Africa
Middle East and Africa contribute approximately 6% of the virus filtration market. This growth is driven by expanding healthcare access, increasing focus on quality manufacturing, and rising demand for safe therapeutic products. Partnerships with global market leaders strengthen regional market development.
Latin America
Latin America holds around 4% of the virus filtration market. Growth drivers include rising biopharmaceutical production, increasing adoption of advanced virus filtration technologies, and efforts to improve healthcare infrastructure. Regional initiatives to promote domestic manufacturing further support market expansion.
Virus Filtration Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Virus Filtration Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Comprehensive Market Impact Matrix
This matrix outlines how core market forces—Drivers, Restraints, and Opportunities—affect key business dimensions including Growth, Competition, Customer Behavior, Regulation, and Innovation.
| Market Forces ↓ / Impact Areas → | Market Growth Rate | Competitive Landscape | Customer Behavior | Regulatory Influence | Innovation Potential |
|---|---|---|---|---|---|
| Drivers | High impact (e.g., tech adoption, rising demand) | Encourages new entrants and fosters expansion | Increases usage and enhances demand elasticity | Often aligns with progressive policy trends | Fuels R&D initiatives and product development |
| Restraints | Slows growth (e.g., high costs, supply chain issues) | Raises entry barriers and may drive market consolidation | Deters consumption due to friction or low awareness | Introduces compliance hurdles and regulatory risks | Limits innovation appetite and risk tolerance |
| Opportunities | Unlocks new segments or untapped geographies | Creates white space for innovation and M&A | Opens new use cases and shifts consumer preferences | Policy shifts may offer strategic advantages | Sparks disruptive innovation and strategic alliances |
Drivers, Restraints and Opportunity Analysis
Drivers
- Increasing Demand for Biopharmaceuticals
- Stringent Regulatory Requirements for Viral Safety
-
Advancements in Filtration Technologies -The biopharmaceutical and bioprocessing industries. The development of high-performance virus filters with improved pore structure, membrane integrity, and contaminant retention has enhanced the safety and efficacy of final drug products. These next-generation filters are capable of efficiently removing a wide range of viral contaminants without compromising product quality or biological activity.
The emergence of nanofiber-based membranes and advanced polymer technologies has improved the mechanical strength and flow rate capacity of virus filtration systems, allowing for faster processing with reduced filter clogging. These innovations are enabling manufacturers to meet regulatory guidelines more effectively while maintaining cost efficiency and production scalability.
Moreover, the integration of automated filtration platforms and real-time monitoring systems ensures consistent performance across batches and improves process validation. These advancements support the growing demand for high-throughput filtration in vaccine manufacturing, gene therapy, and monoclonal antibody production.
As regulatory agencies increase their focus on viral safety assurance, the adoption of technologically superior filtration systems is becoming essential. These advancements not only enhance product integrity but also support long-term growth by enabling faster, safer, and more scalable viral clearance processes.
Restraints
- High Cost of Virus Filtration Processes
- Potential Impact on Product Integrity
-
Limited Scalability of Filtration Systems - Particularly when transitioning from small-scale research to large-scale bioproduction. Many virus filters perform well in controlled laboratory settings but fail to maintain consistent performance at commercial volumes due to issues like pressure drop, membrane fouling, and flow rate inefficiencies.
This limitation can result in frequent filter replacement, increased operational downtime, and higher production costs. Biomanufacturers often struggle to adapt filtration technologies to meet the scale demands of clinical trials or vaccine campaigns, creating process bottlenecks and potential supply chain delays.
Another complication is the lack of universal filtration solutions. Different biologics require customized filtration approaches based on molecule size, process viscosity, and buffer compositions, limiting the versatility and scalability of existing technologies. This creates a reliance on trial-and-error methods and increases validation complexity.
To overcome these barriers, the industry must invest in the development of modular filtration platforms and scalable membrane materials that maintain performance under high-throughput conditions. Without addressing scalability, virus filtration may remain a bottleneck in modern biologic manufacturing workflows.
Opportunities
- Expansion of Biologics Manufacturing
- Growing Emphasis on Vaccine Development
-
Adoption of Single-Use Filtration Systems - The rising adoption of single-use filtration systems is creating significant opportunities in the virus filtration market. These disposable, pre-sterilized systems offer a flexible and cost-efficient alternative to traditional stainless-steel-based filtration setups. Their ability to reduce cross-contamination risks and cleaning validation efforts makes them highly attractive for multi-product manufacturing facilities.
Single-use systems are particularly beneficial in the biopharmaceutical sector, where batch production and quick changeovers are essential. These systems support faster turnaround times, lower capital investment, and decreased labor requirements, all of which contribute to more agile and scalable production processes.
The integration of pre-assembled filtration modules, along with closed-loop system designs, improves process sterility and reduces the risk of human error. As global demand grows for safe biologics and personalized therapies, single-use systems provide the reliability and flexibility needed for efficient virus clearance.
With the biomanufacturing industry trending toward modular facilities and continuous processing, the scalability and operational simplicity of single-use filtration systems are expected to fuel widespread adoption. This trend offers a powerful avenue for manufacturers seeking to improve product safety, reduce costs, and enhance regulatory compliance.
Virus Filtration Market Competitive Landscape Analysis
Key players in Virus Filtration Market include:
- Merck KGaA
- Danaher
- Sartorius AG
- Thermo Fisher Scientific Inc
- GE Healthcare
- Charles River Laboratories
- Asahi Kasei Medical Co Ltd
- WuXi AppTec
- Lonza
- Clean Biologics
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Market Share Analysis
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Technology
- Market Snapshot, By Product
- Market Snapshot, By Application
- Market Snapshot, By End-User
- Market Snapshot, By Region
- Virus Filtration Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
-
Increasing Demand for Biopharmaceuticals
-
Stringent Regulatory Requirements for Viral Safety
-
Advancements in Filtration Technologies
-
- Restraints
-
High Cost of Virus Filtration Processes
-
Potential Impact on Product Integrity
-
Limited Scalability of Filtration Systems
-
- Opportunities
-
Expansion of Biologics Manufacturing
-
Growing Emphasis on Vaccine Development
-
Adoption of Single-Use Filtration Systems
-
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Virus Filtration Market, By Technology, 2021 - 2031 (USD Million)
-
Filtration
-
Chromatography
-
- Virus Filtration Market, By Product, 2021 - 2031 (USD Million)
- Consumables
- Instruments
- Services
-
Virus Filtration Market, By Application, 2021 - 2031 (USD Million)
-
Biologicals
-
Medical Devices
-
Water Purification
-
- Virus Filtration Market, By End-User, 2021 - 2031 (USD Million)
-
Hospitals and Clinics
-
Pharmaceutical Companies
-
Medical Device Companies
-
Contract Testing Organizations
-
Others
-
- Virus Filtration Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Virus Filtration Market, By Technology, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Merck KGaA
- Danaher
- Sartorius AG
- Thermo Fisher Scientific Inc
- GE Healthcare
- Charles River Laboratories
- Asahi Kasei Medical Co Ltd
- WuXi AppTec
- Lonza
- Clean Biologics
- Company Profiles
- Analyst Views
- Future Outlook of the Market